Add to ORKGProtocol and report of second testing round SCOPE study (Sars-COv-2 seroPrEvalence). Version 1.3, dd. 27/08/202
Objectives: This study aimed to report the results of SARS-CoV-2 PCR-based screening campaigns condu...
Background: The Grand Hôpital de Charleroi is a large non-academic Belgian hospital that treated a l...
OBJECTIVES: To describe prevalence and incidence of anti-SARS-CoV-2 antibodies among Belgian hospita...
Protocol and report of first testing round SCOPE study (Sars-COv-2 seroPrEvalence). Version 1.5, dd....
Brief communication: preliminary results of the SCOPE study (Sars-COv-2 seroPrEvalence). dd. 01/09/2...
In a previous study in Belgian nursing homes (NH) during the first wave of the COVID-19 pandemic, we...
In the SCOPE study, we monitored SARS-CoV-2 antibodies in a national sample of residents and staff f...
Seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibodies, using...
The SCOPE study assesses the prevalence of anti-SARS-CoV-2 antibodies among a representat...
BACKGROUND: Nursing home residents (NHR) and staff have been disproportionally affected by the COVID...
In April 2020, Belgium experienced high numbers of fatal COVID-19 cases among nursing home (NH) resi...
In a previous study in Belgian nursing homes (NH) during the first wave of the COVID-19 pandemic, we...
peer reviewedIn the SCOPE study, we monitored SARS-CoV-2 antibodies in a national sample of resident...
The burden of COVID-19 has disproportionately impacted the elderly, who are at increased risk of sev...
This study aims to evaluate SARS-CoV-2 seroprevalence among health care workers (HCWs) and to assess...
Objectives: This study aimed to report the results of SARS-CoV-2 PCR-based screening campaigns condu...
Background: The Grand Hôpital de Charleroi is a large non-academic Belgian hospital that treated a l...
OBJECTIVES: To describe prevalence and incidence of anti-SARS-CoV-2 antibodies among Belgian hospita...
Protocol and report of first testing round SCOPE study (Sars-COv-2 seroPrEvalence). Version 1.5, dd....
Brief communication: preliminary results of the SCOPE study (Sars-COv-2 seroPrEvalence). dd. 01/09/2...
In a previous study in Belgian nursing homes (NH) during the first wave of the COVID-19 pandemic, we...
In the SCOPE study, we monitored SARS-CoV-2 antibodies in a national sample of residents and staff f...
Seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibodies, using...
The SCOPE study assesses the prevalence of anti-SARS-CoV-2 antibodies among a representat...
BACKGROUND: Nursing home residents (NHR) and staff have been disproportionally affected by the COVID...
In April 2020, Belgium experienced high numbers of fatal COVID-19 cases among nursing home (NH) resi...
In a previous study in Belgian nursing homes (NH) during the first wave of the COVID-19 pandemic, we...
peer reviewedIn the SCOPE study, we monitored SARS-CoV-2 antibodies in a national sample of resident...
The burden of COVID-19 has disproportionately impacted the elderly, who are at increased risk of sev...
This study aims to evaluate SARS-CoV-2 seroprevalence among health care workers (HCWs) and to assess...
Objectives: This study aimed to report the results of SARS-CoV-2 PCR-based screening campaigns condu...
Background: The Grand Hôpital de Charleroi is a large non-academic Belgian hospital that treated a l...
OBJECTIVES: To describe prevalence and incidence of anti-SARS-CoV-2 antibodies among Belgian hospita...